Please sign in to follow a disease.
Almonds before meals: a simple trick to tame blood sugar?
NCT ID NCT07603739
First seen Jun 25, 2026 · Last updated Jul 17, 2026 · Updated 3 times
Summary
This study looks at whether eating a small handful of almonds (about 18 grams) 30 minutes before a meal can reduce the rise in blood sugar after eating. Researchers will test 25 adults with prediabetes, comparing blood sugar levels after meals with and without almonds. They also want to see if some people consistently benefit more than others.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- almonds (18 g before meals)
- What this could lead to
- If it works, this could point toward a simple dietary strategy to help manage blood sugar spikes in people with prediabetes.
- What could go wrong
- This is a small, early-stage study with only 25 participants, so results may not apply to everyone. The effect of almonds on blood sugar may be small or inconsistent.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 25 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2026
- Expected to finish
-
Jul 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
25 to 50 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults aged 25-50 years * Females over 40 years must have had a cycle in the last 6 months * Body mass index (BMI) at least 18.5 and at most 55.0 kg/m2 * Impaired blood glucose by at least one of the following criteria: * Fasting blood glucose at least 100 mg/dL (5.6 mmol/L) and less than 125 mg/dL (6.9 mmol/L) * HbA1c at least 5.7% and less than 6.5% * Willing and able to comply with study foods * Willing and able to ingest acetaminophen as part of study procedures * Able to read, speak, and understand English Exclusion Criteria: * Weight change ≥5% in past 6 months, actively trying to lose weight, or unwilling to remain weight stable throughout the study based on self-report * Recent history within past 12 months of medical provider-diagnosed cardiovascular, renal, or liver disease that required treatment * Current or past diagnosis of cancer (except skin cancer) in the last 5 years * Current or past diagnosis of type 1 or type 2 diabetes * Recent history within past 12 months of medical provider-diagnosed gastrointestinal or neurological disorders if not managed/stable for at least 3 months (with or without treatment) * Recent history within past 12 months of medical provider-diagnosed psychiatric disorders including eating disorders or severe depression if not managed/stable for at least 3 months (with or without treatment) * Food allergies or other reasons preventing consumption of study foods * Any glucose-lowering medication except biguanides (e.g., Metformin) if stable for at least 3 months or incretins (i.e., GLP-1RA-based) if stable for at least 3 months * Current smoking or vaping or history of smoking or vaping in the past 6 months * Binge and/or heavy drinking (i.e., \>3 drinks on any given occasion and/or \>7 drinks/week) * Currently pregnant or planning to become pregnant or breastfeed in the next 3 months by self-report
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Glucose control are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Pennington Biomedical Research Center
RECRUITINGBaton Rouge, Louisiana, 70808, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can four minutes of hard exercise match a longer workout for blood sugar?
- Can a glucose app that predicts lows calm diabetes fears?
- Can almond, soy, or oat milk match dairy for nutrient absorption?
- Protein and saline mist may cut bleeding risk after tonsil removal
- Can personalized sound waves boost brain health in dementia?
- Can exposing food marketing tricks on instagram make young adults eat healthier?